How has been the historical performance of the SMS Pharma.?

Answer:The historical performance of SMS Pharma shows a significant upward trend in net sales and profitability over the years, particularly from March 2023 to March 2025.

Breakdown:
SMS Pharma's net sales increased from Rs 522.05 crore in March 2023 to Rs 782.75 crore in March 2025, reflecting a robust growth trajectory. The total operating income followed a similar pattern, rising from Rs 522.05 crore in March 2023 to Rs 782.75 crore in March 2025. Despite rising raw material costs, which grew from Rs 299.72 crore in March 2023 to Rs 501.87 crore in March 2025, the company managed to improve its operating profit, which reached Rs 145.22 crore in March 2025, up from Rs 59.39 crore in March 2023. Profit before tax also saw a notable increase, climbing from Rs 5.35 crore in March 2023 to Rs 92.34 crore in March 2025. Consequently, profit after tax surged from Rs 3.88 crore in March 2023 to Rs 67.40 crore in March 2025. The consolidated net profit also improved significantly, going from a loss of Rs 7.06 crore in March 2023 to a profit of Rs 69.14 crore in March 2025. The company's total assets increased from Rs 879.61 crore in March 2023 to Rs 1,034.09 crore in March 2024, indicating a solid growth in its financial position. Overall, SMS Pharma has demonstrated a strong recovery and growth in its financial metrics over the past few years.